Sale

Pen Needles Market

Global Pen Needles Market Share, Growth, Report: By Product Type: Standard Pen Needles, Safety Pen Needles; By Needles Length: 4mm, 5mm, 6mm, 8mm, 10mm, 12mm; By Usability: Reusable Pen Needles, Disposable Pen Needles; By Therapy: Insulin, Others; By Application; By End User; Regional Analysis; Supplier Landscape; 2024-2032

Global Pen Needles Market Outlook

The global pen needles market size attained a value of USD 3.51 billion in 2023. The market is likely to grow further at a CAGR of 13.1% during the forecast period of 2024-2032 to attain a value of USD 10.62 billion by 2032.

 

Global Pen Needles Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Increasing Demand for Insulin Pens to Augment the Pen Needles Industry Growth

The global pen needles industry is driven by the increase in the preference for insulin pens over syringes and vials on account of their user-friendly and less intrusive mechanism. The diabetic patients are the most common users of insulin pens because of the requirement of multiple daily insulin injections and with the rising prevalence of diabetes due to poor lifestyle choices, there has been a surge in demand for insulin pens. Furthermore, the adoption of insulin pens has increased as a result of technological advancements and expansion of the healthcare industry due to COVID-19. Meanwhile, insulin pens with colour codes have greatly reduced patient pen section errors, thus, significantly contributing to the growth of the pen needles industry.

 

North America to Provide Significant Growth Opportunities to the Pen Needles Industry

The rising incidences of autoimmune disorders, hormonal disorders, and a variety of other diseases are driving the market expansion in North America. Changes in eating habits, obesity issues, and sedentary lifestyles are some of the major causes contributing to the spread of these diseases among the population in the region. According to the World Fact Book, the United States alone has a 36.2% rate of obesity, making it one of the largest consumers of pen needles. Meanwhile, the increase in research and development activities and the rapid technological advancements in North America are projected to further propel the industry growth during the forecast period.

 

Pen Needles: Market Segmentation

A pen needle is a device used to inject medication beneath the skin. They are usually used for medications that need to be repeatedly injected over a short period of time. It increases patient's adherence by making the process of drug administration easier and convenient. Pen needles serve as an efficient alternative to the traditional syringe and vials, as they can help people with limited dexterity, poor vision, or portability requirements to easily administer medication on time.

 

Global Pen Needles Market by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

By product type, the market is divided into:

  • Standard Pen Needles
  • Safety Pen Needles

Based on needle length, the industry can be segmented into:

  • 4 mm
  • 5 mm
  • 6 mm
  • 8 mm
  • 10 mm
  • 12 mm

On the basis of therapy, the industry can be categorised into:

  • Insulin
  • Glucagon-like-Peptide-1 (GLP-1)
  • Growth Hormone

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Pen Needles Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Growing Prevalence of Diabetes to Bolster the Growth of the Pen Needles Industry

The global pen needles industry is being driven by the growing incidences of diabetes, as a diabetic patient requires multiple daily insulin injections. It is a severe public health issue that has reached epidemic proportions around the world. Every year around 18 million individuals die because of cardiovascular disease, for which diabetes and hypertension are key risk factors. To counter this, various private corporations and governments have started investing heavily to promote the use of insulin pens, further boosting the growth of the pen needles industry. Over the forecast period, the growing adoption of pen needles in emerging countries such as China, India, and Brazil to fight diabetes is projected to significantly contribute to the industry growth.

 

Key Industry Players in the Global Pen Needles Market

The report gives a detailed analysis of the following key players in the global pen needles market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Becton, Dickinson and Company
  • Novo Nordisk A/S
  • Ypsomed Holding AG
  • Owen Mumford, Ltd.
  • Htl-Strefa S.A
  • B. Braun Melsungen AG
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product Type
  • Needles Length
  • Usability
  • Therapy
  • Application
  • End User
  • Region
Breakup by Product Type
  • Standard Pen Needles
  • Safety Pen Needles
Breakup by Needles Length
  • 4mm
  • 5mm
  • 6mm
  • 8mm
  • 10mm
  • 12mm
Breakup by Usability
  • Reusable Pen Needles
  • Disposable Pen Needles
Breakup by Therapy
  • Insulin
  • Glucagon-like-Peptide-1 (GLP-1)
  • Growth Hormone
Breakup by Application
  • Diabetes
  • Growth Hormone Deficiency
  • Others
Breakup by End User
  • Hospitals
  • Clinics
  • Over The Counter
  • Home Healthcare
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Novo Nordisk A/S
  • YPSOMED
  • B. Braun Melsungen AG
  • HTL-STREFA S.A.
  • Terumo Corporation
  • BD
  • Owen Mumford Inc.
  • UltiMed, Inc.
  • Artsana S.p.A.
  • Trividia Health, Inc
  • STAT Medical Devices
  • Simple Diagnostics
  • Pietrasanta Pharma SpA
  • Henso Medical (Hangzhou) Co., Ltd.
  • Shanghai Beipu Medical Co., Ltd
  • Zhejiang Kindly Medical Devices Co., Ltd.
  • ARKRAY, Inc.
  • AstraZeneca
  • GlaxoSmithKline plc
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope
    1.4    Research Methodology
2    Executive Summary
3    Global Pen Needles Market Overview 

    3.1    Global Pen Needles Market Historical Value (2017-2023) 
    3.2    Global Pen Needles Market Forecast Value (2024-2032)
4    Global Pen Needles Market Landscape
    4.1    Global Pen Needles Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Pen Needles Product Landscape
        4.2.1    Analysis by Product Type
        4.2.2    Analysis by Applications
        4.2.3    Analysis by End User
5    Global Pen Needles Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Pen Needles Market Segmentation
    6.1    Global Pen Needles Market by Product Type
        6.1.1    Market Overview
        6.1.2    Standard Pen Needles
        6.1.3    Safety Pen Needles
    6.2    Global Pen Needles Market by Needles Length
        6.2.1    Market Overview
        6.2.2    4mm
        6.2.3    5mm
        6.2.4    6mm
        6.2.5    8mm
        6.2.6    10mm
        6.2.7    12mm
    6.3    Global Pen Needles Market by Usability
        6.3.1    Market Overview
        6.3.2    Reusable Pen Needles
        6.3.3    Disposable Pen Needles
    6.4    Global Pen Needles Market by Therapy
        6.4.1    Market Overview
        6.4.2    Insulin
        6.4.3    Glucagon-like-Peptide-1 (GLP-1)
        6.4.4    Growth Hormone
    6.5    Global Pen Needles Market by Application
        6.5.1    Market Overview
        6.5.2    Diabetes
        6.5.3    Growth Hormone Deficiency
        6.5.4    Others
    6.6    Global Pen Needles Market by End User
        6.6.1    Market Overview
        6.6.2    Hospitals
        6.6.3    Clinics
        6.6.4    Over The Counter
        6.6.5    Home Healthcare
        6.6.6    Others
    6.7    Global Pen Needles Market by Region
        6.7.1    Market Overview
        6.7.2    North America 
        6.7.3    Europe
        6.7.4    Asia Pacific
        6.7.5    Latin America
        6.7.6    Middle East and Africa
7    North America Pen Needles Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Pen Needles Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Pen Needles Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Pen Needles Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Pen Needles Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Supplier Landscape
    17.1    Novo Nordisk A/S
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications
    17.2    YPSOMED
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    B. Braun Melsungen AG
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    HTL-STREFA S.A.
        17.4.1    Financial Analysis
        17.4.2    Product Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    Terumo Corporation
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    BD
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    Owen Mumford Inc.
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    UltiMed, Inc.
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    Artsana S.p.A.
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    Trividia Health, Inc
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications
    17.11    STAT Medical Devices
        17.11.1    Financial Analysis
        17.11.2    Product Portfolio
        17.11.3    Demographic Reach and Achievements
        17.11.4    Mergers and Acquisitions
        17.11.5    Certifications
    17.12    Simple Diagnostics
        17.12.1    Financial Analysis
        17.12.2    Product Portfolio
        17.12.3    Demographic Reach and Achievements
        17.12.4    Mergers and Acquisitions
        17.12.5    Certifications
    17.13    Pietrasanta Pharma SpA
        17.13.1    Financial Analysis
        17.13.2    Product Portfolio
        17.13.3    Demographic Reach and Achievements
        17.13.4    Mergers and Acquisitions
        17.13.5    Certifications
    17.14    Henso Medical (Hangzhou) Co., Ltd.
        17.14.1    Financial Analysis
        17.14.2    Product Portfolio
        17.14.3    Demographic Reach and Achievements
        17.14.4    Mergers and Acquisitions
        17.14.5    Certifications
    17.15    Shanghai Beipu Medical Co., Ltd
        17.15.1    Financial Analysis
        17.15.2    Product Portfolio
        17.15.3    Demographic Reach and Achievements
        17.15.4    Mergers and Acquisitions
        17.15.5    Certifications
    17.16    Zhejiang Kindly Medical Devices Co., Ltd.
        17.16.1    Financial Analysis
        17.16.2    Product Portfolio
        17.16.3    Demographic Reach and Achievements
        17.16.4    Mergers and Acquisitions
        17.16.5    Certifications
    17.17    ARKRAY, Inc.
        17.17.1    Financial Analysis
        17.17.2    Product Portfolio
        17.17.3    Demographic Reach and Achievements
        17.17.4    Mergers and Acquisitions
        17.17.5    Certifications
    17.18    AstraZeneca
        17.18.1    Financial Analysis
        17.18.2    Product Portfolio
        17.18.3    Demographic Reach and Achievements
        17.18.4    Mergers and Acquisitions
        17.18.5    Certifications
    17.19    GlaxoSmithKline plc
        17.19.1    Financial Analysis
        17.19.2    Product Portfolio
        17.19.3    Demographic Reach and Achievements
        17.19.4    Mergers and Acquisitions
        17.19.5    Certifications
18    Global Pen Needles Market - Distribution Model (Additional Insight)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

In 2023, the market attained a value of approximately USD 3.51 billion.

The market is expected to grow at a CAGR of 13.1% from 2024 to 2032 to reach a value of USD 10.62 billion by 2032.

The major drivers of the industry, such as technological advancements, the expansion of medical industry, the reducing patient pen section error, the increasing research and development (R&D) activities, and the convenience and portability of pen needles over syringe and vials are expected to aid the market growth.

The key market trends guiding the growth of the industry include the increase in diabetes incidences, along with other autoimmune or hormonal diseases, obesity and sedentary lifestyle.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major product types of pen needles are standard pen needles and safety pen needles.

The various needle lengths of pen needles are 4 mm, 5 mm, 6 mm, 8 mm, 10 mm, and 12 mm.

The different therapies of pen needles in the market are insulin, glucagon-like-peptide-1(GLP-1) and growth hormone.

The major players in the industry are Becton, Dickinson and Company, NoVo Nordisk A/S, Ypsomed Holding AG, Owen Mumford, Ltd., Htl-Strefa S.A, and B. Braun Melsungen AG, among others.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER